Fang Xie
About Fang Xie
Fang Xie serves as the Vice President of Biometrics at Insmed Incorporated, where he has worked since 2018. He has extensive experience in biostatistics, having held senior roles at several pharmaceutical companies including Cephalon, Teva Pharmaceuticals, and Amgen.
Current Role at Insmed
Fang Xie serves as the Vice President of Biometrics at Insmed Incorporated. He has held this position since 2018, contributing to the company's efforts in biostatistics and data analysis in New Jersey, United States. His role involves overseeing biometrics functions, ensuring the integrity and accuracy of clinical trial data, and supporting regulatory submissions.
Previous Experience in Biostatistics
Fang Xie has extensive experience in biostatistics across various pharmaceutical companies. He worked at Cephalon as Senior Director of Biostatistics from 2004 to 2011, and at Teva Pharmaceuticals as Senior Director, Head of Global Project Biostatistics from 2011 to 2013. Additionally, he held roles at Amgen, Aventis Behring, Pfizer, and GSK Vaccines, accumulating a wealth of knowledge in statistical methodologies and clinical trial design.
Education and Expertise
Fang Xie earned his Bachelor's degree from Peking University and later obtained a Doctor of Philosophy from Columbia University in the City of New York. His educational background provides a strong foundation in statistical theory and its application in the pharmaceutical industry, enhancing his expertise in biostatistics.
Career Timeline
Fang Xie's career spans several prominent roles in biostatistics. He began as a Senior Statistician at GSK Vaccines in 1998 and progressed through various positions, including Associate Director roles at Aventis Behring and Pfizer. He served as Head of Biostatistics and Programming at CSL Behring from 2014 to 2018 before joining Insmed. His career reflects a consistent focus on advancing biostatistical practices in clinical research.